"Age-related macular degeneration (AMD)"- Market Insights, Epidemiology and Market Forecast-2020

  • ID: 3645173
  • Drug Pipelines
  • 70 pages
  • DelveInsight
UP TO OFF
until Dec 31st 2018
1 of 3
This Age-related macular degeneration (AMD) - Market Insights, Epidemiology and Market Forecast-2020” report provides an overview of the disease and global market trends for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Age-related macular degeneration (AMD) forecasted market share for ten years to 2020 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Age-related macular degeneration (AMD) till 2020.

Key Coverage and Benefits

- The report will help in developing business strategies by understanding the trends shaping and driving the global Age-related macular degeneration (AMD) market.
- Identifying patient populations in the global “Age-related macular degeneration (AMD)market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the best opportunities for Age-related macular degeneration (AMD) therapeutics in each of the markets covered.
- To understand the future market competition in the global Age-related macular degeneration (AMD) therapeutics market and Insightful review of the key market drivers and barriers.

Scope

- Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
- Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
- The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020.
- It also provides Age-related macular degeneration (AMD) for United States, EU5 and Japan from 2010 and forecasted Market to 2020.

Note*: This report requires 5-10 business days to complete.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
Table of Contents

- Age-related macular degeneration (AMD) overview
- Pathophysiology
- Symptoms of disease
- Etiology of disease
- Diagnosis of disease
- Treatment of disease
- Overview of Marketed drugs
- Drug Description
- Mechanism of Action
- Pharmacokinetics Properties
- Marketed Details
- Patent Information
- Patent Exclusivity Expiry Assessment United States (US)
- Patents Details
- Historical and Forecasted sales of marketed molecules in the Global Age-related macular degeneration (AMD) Market
- Global Epidemiology of Age-related macular degeneration (AMD) Forecasted to 2020
- Global Market (2011-2015)
- Global Forecasted Market (2016-2020)
- Global Market by Geography
- Market of US (2011-2015)
- Forecasted Market of US (2016-2020)
- Market of Europe
- Market of Germany (2011-2015)
- Forecasted Market of Germany (2016-2020)
- Market of United Kingdom (2011-2015)
- Forecasted Market of United Kingdom (2016-2020)
- Market of France (2011-2015)
- Forecasted Market of France (2016-2020)
- Market of Italy (2011-2015)
- Forecasted Market of Italy (2016-2020)
- Market of Spain (2011-2015)
- Forecasted Market of Spain (2016-2020)
- Market of Japan (2011-2015)
- Forecasted Market of Japan (2016-2020)
- Market of ROW (2011-2015)
- Forecasted Market of ROW (2016-2020)
- Appendix
- Report Methodology
- Consulting Services
- Disclaimer
- Report Purchase Options
- About us

List of Tables

- Table 1: Drug Description
- Table 2: Drug, Marketed Details United States (US)
- Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
- Table 4: Drug, Patent Details for US
- Table 5: Age-related macular degeneration (AMD) Drug Sales (USD Millions)-2020
- Table 6: Global Epidemiology of Age-related macular degeneration (AMD) (2011-2020)
- Table 7: Age-related macular degeneration (AMD) Global Market (USD Millions), (2011-2015)
- Table 8: Age-related macular degeneration (AMD) Global Market (USD Millions), (2016-2020)
- Table 9: Age-related macular degeneration (AMD) US Market (USD Millions), (2011-2015)
- Table 10: Age-related macular degeneration (AMD) US Market (USD Millions), (2016-2020)
- Table 11: Age-related macular degeneration (AMD) Germany Market (USD Millions), (2011-2015)
- Table 12: Age-related macular degeneration (AMD) Germany Market (USD Millions), (2016-2020)
- Table 13: Age-related macular degeneration (AMD) United Kingdom Market (USD Millions), (2011-2015)
- Table 14: Age-related macular degeneration (AMD) United Kingdom Market (USD Millions), (2016-2020)
- Table 15: Age-related macular degeneration (AMD) France Market (USD Millions), (2011-2015)
- Table 16: Age-related macular degeneration (AMD) France Market (USD Millions), (2016-2020)
- Table 17: Age-related macular degeneration (AMD) Italy Market (USD Millions), (2011-2015)
- Table 18: Age-related macular degeneration (AMD) Italy Market (USD Millions), (2016-2020)
- Table 19: Age-related macular degeneration (AMD) Spain Market (USD Millions), (2011-2015)
- Table 20: Age-related macular degeneration (AMD) Spain Market (USD Millions), (2016-2020)
- Table 21: Age-related macular degeneration (AMD) Japan Market (USD Millions), (2011-2015)
- Table 22: Age-related macular degeneration (AMD) Japan Market (USD Millions), (2016-2020)
- Table 23: Age-related macular degeneration (AMD) ROW Market (USD Millions), (2011-2015)
- Table 24: Age-related macular degeneration (AMD) ROW Market (USD Millions), (2016-2020)

List of Figures

- Figure 1: Age-related macular degeneration (AMD) Drug Sales (USD Millions)-2020
- Figure 2: Global Epidemiology of Age-related macular degeneration (AMD) (2011-2020)
- Figure 3: Age-related macular degeneration (AMD) Global Market (USD Millions), (2011-2015)
- Figure 4: Age-related macular degeneration (AMD) Global Market (USD Millions), (2016-2020)
- Figure 5: Age-related macular degeneration (AMD) US Market (USD Millions), (2011-2015)
- Figure 6: Age-related macular degeneration (AMD) US Market (USD Millions), (2016-2020)
- Figure 7: Age-related macular degeneration (AMD) Germany Market (USD Millions), (2011-2015)
- Figure 8: Age-related macular degeneration (AMD) Germany Market (USD Millions), (2016-2020)
- Figure 9: Age-related macular degeneration (AMD) United Kingdom Market (USD Millions), (2011-2015)
- Figure 10: Age-related macular degeneration (AMD) United Kingdom Market (USD Millions), (2016-2020)
- Figure 11: Age-related macular degeneration (AMD) France Market (USD Millions), (2011-2015)
- Figure 12: Age-related macular degeneration (AMD) France Market (USD Millions), (2016-2020)
- Figure 13: Age-related macular degeneration (AMD) Italy Market (USD Millions), (2011-2015)
- Figure 14: Age-related macular degeneration (AMD) Italy Market (USD Millions), (2016-2020)
- Figure 15: Age-related macular degeneration (AMD) Spain Market (USD Millions), (2011-2015)
- Figure 16: Age-related macular degeneration (AMD) Spain Market (USD Millions), (2016-2020)
- Figure 17: Age-related macular degeneration (AMD) Japan Market (USD Millions), (2011-2015)
- Figure 18: Age-related macular degeneration (AMD) Japan Market (USD Millions), (2015-2020)
- Figure 19: Age-related macular degeneration (AMD) ROW Market (USD Millions), (2011-2015)
- Figure 20: Age-related macular degeneration (AMD) ROW Market (USD Millions), (2016-2020)
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll